DNLI
Price
$21.93
Change
+$0.26 (+1.20%)
Updated
Jan 17 closing price
Capitalization
3.16B
43 days until earnings call
TLPPF
Price
$16.70
Change
+$0.70 (+4.38%)
Updated
Jan 17 closing price
Capitalization
5.53B
Ad is loading...

DNLI vs TLPPF

Header iconDNLI vs TLPPF Comparison
Open Charts DNLI vs TLPPFBanner chart's image
Denali Therapeutics
Price$21.93
Change+$0.26 (+1.20%)
Volume$868.18K
Capitalization3.16B
Telix Pharmaceutical
Price$16.70
Change+$0.70 (+4.38%)
Volume$2.16K
Capitalization5.53B
DNLI vs TLPPF Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. TLPPF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and TLPPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (DNLI: $21.93 vs. TLPPF: $16.70)
Brand notoriety: DNLI and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 87% vs. TLPPF: 48%
Market capitalization -- DNLI: $3.16B vs. TLPPF: $5.53B
DNLI [@Biotechnology] is valued at $3.16B. TLPPF’s [@Biotechnology] market capitalization is $5.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while TLPPF’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 2 bearish.
  • TLPPF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than TLPPF.

Price Growth

DNLI (@Biotechnology) experienced а +14.82% price change this week, while TLPPF (@Biotechnology) price change was +14.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($5.53B) has a higher market cap than DNLI($3.16B). TLPPF YTD gains are higher at: 11.519 vs. DNLI (7.606). TLPPF has higher annual earnings (EBITDA): 73M vs. DNLI (-496.05M). TLPPF has higher revenues than DNLI: TLPPF (637M) vs DNLI (0).
DNLITLPPFDNLI / TLPPF
Capitalization3.16B5.53B57%
EBITDA-496.05M73M-680%
Gain YTD7.60611.51966%
P/E RatioN/A166.11-
Revenue0637M-
Total Cash837MN/A-
Total Debt52.5MN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLITLPPF
RSI
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
76%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
69%
MACD
ODDS (%)
Bullish Trend 12 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
60%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
78%
Bearish Trend 21 days ago
65%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMGX10.830.07
+0.65%
DFA Emerging Markets Trgt Val Instl
PIIFX25.780.16
+0.62%
Pioneer International Equity A
GWSIX19.220.11
+0.58%
Gabelli Focused Gr and Inc I
FSOSX13.760.04
+0.29%
Fidelity Series Overseas
MGLLX16.010.02
+0.13%
MFS Global Real Estate R3

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
+4.38%
GLMD - TLPPF
25%
Poorly correlated
-1.02%
DNLI - TLPPF
24%
Poorly correlated
+1.20%
BEAM - TLPPF
24%
Poorly correlated
+0.17%
RXRX - TLPPF
23%
Poorly correlated
+2.03%
JANX - TLPPF
23%
Poorly correlated
+0.27%
More